Week 10: Diabetes Drugs

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/129

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

130 Terms

1
New cards

Type 1 vs Type 2 diabetes

  • Type 1: body doesn’t make any insulin

  • Type 2: insulin resistance — cells ignore insulin

2
New cards

What contributes to the development of T1 diabetes?

  • Genetics

  • Celiac

  • Thyroid disease

3
New cards

Risk factors for T2 diabetes

  • Males

  • Older age

  • Having a first-degree relative with it 

  • BMI >25

  • Sedentary lifestyle 

  • CV disease (e.g., hypertension)

4
New cards

Hyperglycemia causes damage to _____ ______

blood vessels 

  • both macrovascular and microvascular

5
New cards

What may occur d/t macrovascular complications r/t hyperglycemia?

  • Peripheral vascular disease 

  • MI 

  • Stroke 

6
New cards

What may occur d/t microvascular complications r/t hyperglycemia?

  • Diabetic nephropathy — renal insufficiency and failure 

  • Diabetic retinopathy — blindness

7
New cards

DM diagnosis — A1C level

A1C ≥6.5%

8
New cards

DM diagnosis — fasting BG

FPG ≥126 mg/dL

9
New cards

DM diagnosis — 2-hour BG levels during oral glucose tolerance test (OGTT)

OGTT ≥200 mg/dL

10
New cards

DM diagnosis — Random BG and symptoms

Random BG ≥200 mg/dL 

AND

Classic symptoms of hyperglycemia (polydipsia, polyphasia, polyuria) or hyperglycemia crisis (DKA)

11
New cards

Diagnostic criteria for pre-diabetes — A1C

A1C 5.7-6.4%

12
New cards

Diagnostic criteria for pre-diabetes —fasting BG

FBG 100-125 mg/dL

  • indicative of impaired fasting glucose

13
New cards

Diagnostic criteria for pre-diabetes — 2 hour BG during oral glucose tolerance test (OGTT)

140-199 mg/dL

  • impaired glucose tolerance 

14
New cards

A1C goal for non-pregnant people with diabetes 

≤ 7%

15
New cards

To achieve an A1C of ≤ 7%, what FBG and postprandial glucose (60-90 min after meal) be? 

  • FBG 80-130 mg/dL

  • Postprandial glucose < 180 mg/dL

16
New cards

What factors contribute to a patient’s A1C goal be higher (>8%)?

  • Older adults (7.5%, 8% for those with significant comorbidities)

  • History of severe hypoglycemia 

  • Advanced complications 

  • Limited life expectancy 

  • Little likelihood of benefit from intensive therapy

17
New cards

Hypoglycemia kills you _____, hyperglycemia kills you ____

  • Hypoglycemia kills you quickly

  • Hyperglycemia kills you slowly

18
New cards

Drugs to treat diabetes (8)

  • Insulin

  • Biguanides

  • Sulfonylureas

  • Thiazolindinediones (glitazones)

  • Glinides (meglinides)

  • DPP-4 inhibitors

  • SGLT2

  • Incretin (GLP-1) mimetics

19
New cards

Biguanide drug

Metformin (glucophage)

20
New cards

Sulfonylurea drug

Glipizide (glucotrol)

21
New cards

Thiazolindinedione name

Pioglitazone (actos)

22
New cards

Glinides name

Repaglinide (Prandin)

23
New cards

DPP-4 inhibitors name

Sitagliptin (Januvia)

24
New cards

SGLT2 name

Canagliflozin (invokana)

25
New cards

Incretin (GLP-1) mimetics names (2)

  • Exenatide IByetta)

  • Semaglutinide (Ozempic)

26
New cards

Diabetes drugs that can cause hypoglycemia (3)

  • Insulin

  • Sulfonylureas

  • Glinides

27
New cards

Insulin

a hormone produced by the pancreas that regulates blood glucose by allowing it to enter cells for energy

28
New cards

Insulin MOA

29
New cards

Glucagon MOA

30
New cards

Goals of pharmacologic therapy

  • Mimicking physiologic insulin production

  • Typically includes a combination of basal & bolus insulin

  • Goal is to effectively manage BG throughout the day & with meal

31
New cards

Basal Insulin 

  • Long acting insulin

  • Continuous insulin effects throughout day/night and between meals

32
New cards

Bolus (Prandial) Insulin

  • Short acting

  • Targets BG after meals and acts similarly to body’s natural insulin response to food

33
New cards

Prandial (Bolus) Insulin types

  • Short-acting: Regular insulin (Humalin R)

  • Rapid-acting: Insulin lispro (Humalog)

  • Ultra-rapid acting: Insulin lispro (Lyumjev)

34
New cards

Basal Insulin types 

  • Intermediate acting: NPH insulin 

  • Long acting: Insulin glargine (Lantus)

  • Ultra-long acting: Insulin glargine/Insulin glargine U300 (Toujeo)

35
New cards

What type of insulin is the only cloudy one?

Intermediate-acting: NPH insulin

36
New cards

What type of insulin cannot be mixed with another insulin?

Long-acting: Insulin glargine (Lantus)

37
New cards

Ultra-Rapid acting onset

1 minute

38
New cards

Ultra-Rapid acting peak (Lispro)

60-170 minutes

39
New cards

Ultra-Rapid acting duration (Lispro - Lyumjev)

4.5-7 hours

40
New cards

Ultra-Rapid acting uses (Lispro - Lyumjev)

  • Multiple daily injection regimens

  • Insulin pump

41
New cards

Rapid-acting onset (Lispro - Humalog)

within 15 minutes

42
New cards

Rapid-acting peak (Lispro - Humalog)

2 hours

43
New cards

Rapid-acting duration (Lispro - Humalog)

4-7 hours

44
New cards

Rapid acting uses (Lispro - Lyumjev)

  • Multiple daily injection regimens 

  • Insulin pump

45
New cards

Short acting onset (Regular insulin - Humalin R)

30 minutes 

46
New cards

Short acting peak (Regular insulin - Humalin R)

2-3 hours

47
New cards

Short acting duration (Regular insulin - Humalin R)

6 hours

48
New cards

Short acting uses (Lispro - Lyumjev)

  • Multiple daily injection (MDI) regimens (SQ)

  • Acute uses: DKA, Hyperkalemia (IV)

49
New cards

Intermediate acting peak (NPH - Humalin N)

6-12 hours

50
New cards

Intermediate acting duration (NPH - Humalin N)

12-18 hours

51
New cards

Intermediate acting duration (NPH - Humalin N)

  • Multiple daily injection regimens

  • often paired with rapid acting or regular insulin to improve mealtime coverage — immediate and longer-term insulin coverage

52
New cards

Long acting onset (Glargine - Lantus)

2-4 hours 

53
New cards

Long acting peak (Glargine - Lantus)

none

54
New cards

Long acting duration (Glargine - Lantus)

20-24 hours

55
New cards

Mixed insulin composition

  • intermediate and rapid acting — Humalog mix

  • 75% insulin lispro protamine and 25% insulin

56
New cards

Mixed insulin onset

15-30 minutes

57
New cards

Mixed insulin peak

1-6.5 hours 

58
New cards

Mixed insulin duration

10-16 hours

59
New cards

How is short-acting insulin effectiveness monitored?

post-prandial BG 

  • 1-2 hours after starting a meal

60
New cards

How is long-acting insulin effectiveness monitored?

fasting BG

  • no caloric intake for 8 hours

61
New cards

How do you mix NPH with short-acting insulin?

Nancy Regan RN

  • Nancy = NPH — inject air into NPH vial 

  • Regan = Regular insulin — inject air into regular insulin vial 

  • R = Regular insulin —  pull out liquid 

  • N = NPH — pull out insulin 

62
New cards

What angle should you administer insulin in a normal-sized person? Thin person?

  • Normal: 45-90°

  • Thin: 45-60°

63
New cards

When should clear insulin be discarded?

If it becomes cloudy

  • except for NPH insulin — it is a cloudy solution 

64
New cards

Is insulin normally give SQ or IM? What is the exception?

  • SQ

  • Regular insulin always uses and IV

65
New cards

What types of insulin is preferred for pump therapy? (3)

Ultra-rapid, rapid, or regular

66
New cards

Premixed insulins are for ___ administration only, NOT for ___ or ___

  • SQ

  • pump or IV

67
New cards

What is the normal concentration of insulins?

100 units/mL

68
New cards

What temperature should insulin be stored in? What temperatures should be avoided? 

  • Refrigerated temperature

  • Do not put insulin in: 

    • NOT frozen — needs to be discarded if it freezes

    • Keep out of extreme heat!

69
New cards

How long can insulin be used after opening?

~30 days

70
New cards

Sliding scale insulin — 4 and 6 units

Give 4 units if BG is 150-200

Give 6 units is BG is 201-250

71
New cards

SQ injection locations (4)

  • Abdomen 

  • Thigh 

  • Butt

  • Upper arm 

72
New cards

Patient education for insulin administration

ensure patients can verbalize understanding of ther regimen and exhibit competency with insulin handling and injection

73
New cards

Hypoglycemia

BG < 70 mg/dL

74
New cards

How can someone prevent hypoglycemia/monitor it?

Monitor BG frequently

75
New cards

Risk factors for hypoglycemia in patients taking insulin

  • NPO (typically pre- or post-surgery)

  • Poor PO intake (N/V, diarrhea)

  • Renal and liver diease

76
New cards

What are the 2 categories of hypoglycemia?

Neurogenic (level 1)

Neuroglycopenic (level 2)

77
New cards

What is neurogenic hypoglycemia and what are the symptoms? What is the BG below? 

Activation of the autonomic NS — BG <70 mg/dL

  • starts with hunger and then follows with sympathetic nervous system symptoms:

    • anxiety

    • tachycardia

    • sweating

    • constriction of skin vessels (cool & clammy)

78
New cards

What is neurogenic hypoglycemia and what are the symptoms? What is the BG below? 

Altered cerebral function — BG < 54 mg/dL — REQUIRES IMMEDIATE INTERVENTION!!!

  • symptoms:

    • Headache

    • problem-solving

    • confusion

    • altered behavior

    • coma

    • seizure

79
New cards

Hypogylcemia treatment: 15-15 rule

  • 15 g fast-acting carbs 

    • Glucose tablets: 4

    • ½ cup of regular juice or soda

  • Recheck BG 15 minutes after giving fast-acting carbs

80
New cards

Hypogylcemia treatment: Glucagon

given when patient is unconscious and is unable to eat or drink

81
New cards

Hypogylcemia treatment: D50

Given when patient is in the hospital/EMS d/t the severity of their hypoglycemia

82
New cards

Glucagon MOA 

Hormone secreted by the alpha cell in the pancreas

  • Increases blood glucose level by stimulating glycogenolysis in the liver

  • Immediately raises blood glucose level (5-20 min)

83
New cards

Lipodystrophy

a complication of insulin administration where there is abnormal loss or abnormal distribution of body fat d/t repeated insulin injections at the same site

  • this will affect the absorption of insulin at that site

84
New cards

Biguanides prototype name

Metformin

85
New cards

Biguinides MOA

  • Inhibits glucose production in liver

  • Improves insulin sensitivity

    • sensitizes insulin receptors in target tissues

86
New cards

Biguanides (Metformin) is often the 1st line therapy for type-__ DM because of…

  • 2

  • Absorption, efficacy, and cost

87
New cards

Side effects of Biguanides (Metformin) (4)

  • Does not cause hypoglycemia when used alone

  • Decreased appetite, nausea, vomiting, diarrhea

  • Decreases absorption of B 12 and folic acid

  • Weight loss: ~7-8 pound

  • Lactic acidosis

88
New cards

What substances can increase risk for Lactic Acidosis toxicity r/t Biguanides (Metformin)? 

  • Alcohol

  • Cimetidine (Tagamet),

  • Iodinated radiocontrast media*

89
New cards

How long must Biguanides (Metformin) be held before and procedure with contrast?

48 hours

90
New cards

Thiazolidinediones (Glitazones) prototype

Pioglitazone 

91
New cards

Thiazolidinediones (Glitazones) MOA

Reduce glucose levels by decreasing insulin resistance and inhibit gluconeogenesis

92
New cards

How long does it take for Thiazolidinediones (Glitazones) to become effective?

2-3 months

93
New cards

Thiazolidinediones (Glitazones) adverse effects

  • Weight gain

  • Increased risk of HF and bone fractures d/t increased weight

    • Do not give this med to patients who are obsess/overweight

94
New cards

Sulfonylurea prototypes (2)

Glipizide XL

Glipizide Immediate release

95
New cards

Sulfonylurea (Glipizide XL and immediate release) Glinides (Repaglinide) MOA

  • Glipizides: Stimulates pancreatic beta cells to increase insulin secretion

  • Repaglinide: same as glipizides, but has rapid absorption and rapid elimination

96
New cards

Who cannot be given Sulfonylureas (Glipizide XL and immediate release) or Glinides (Meglitinides?

those whose pancreas cannot make insulin 

97
New cards

Sulfonylurea (Glipizide XL) onset

2-3 hours

98
New cards

Sulfonylurea (Glipizide XL) peak

6-12 hours

99
New cards

Sulfonylurea (Glipizide XL) duration

24 hours

100
New cards

Sulfonylurea (Glipizide immediate release) onset

30-60 minutes